The pros and cons of lamivudine vs. entecavir in decompensated or severe acute exacerbation of chronic hepatitis B

被引：6
|
作者：
Shouval, Daniel [1 ]
机构：
[1] Hadassah Hebrew Univ Hosp, Liver Unit, IL-91120 Jerusalem, Israel
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 06期
关键词：
LACTIC-ACIDOSIS; NUCLEOSIDE; CIRRHOSIS; ANALOGS;
D O I：
10.1016/j.jhep.2014.03.004
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1108 / 1109
页数：2
相关论文
共 50 条
  • [31] Entecavir vs lamivudine therapy for naive patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure
    Zhang, Yang
    Hu, Xiao-Yu
    Zhong, Sen
    Yang, Fang
    Zhou, Tao-You
    Chen, Guo
    Wang, Yan-Yan
    Luo, Jian-Xing
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (16) : 4745 - 4752
  • [32] Entecavir to treat severe acute hepatitis B
    De Socio, Giuseppe Vittorio L.
    Mercuri, Alessandra
    Di Candilo, Francesco
    Baldelli, Franco
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2009, 41 (09) : 703 - 704
  • [33] Severe Acute Hepatitis B Treated With Entecavir
    De Socio, Giuseppe Vittorio Luigi
    Sgrelli, Alessio
    Tosti, Andrea
    Baldelli, Franco
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2011, 3 (01)
  • [34] A combination treatment of entecavir and early-phase corticosteroid in severe exacerbation of chronic hepatitis B
    Matsumoto, Kazuyuki
    Miyake, Yasuhiro
    Miyatake, Hirokazu
    Takahara, Masahiro
    Imada, Takayuki
    Yagi, Satoru
    Toyokawa, Tatsuya
    Nakatsu, Morihito
    Ando, Masaharu
    Hirohata, Mamoru
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (13) : 1650 - 1652
  • [35] A combination treatment of entecavir and early-phase corticosteroid in severe exacerbation of chronic hepatitis B
    Kazuyuki Matsumoto
    Yasuhiro Miyake
    Hirokazu Miyatake
    Masahiro Takahara
    Takayuki Imada
    Satoru Yagi
    Tatsuya Toyokawa
    Morihito Nakatsu
    Masaharu Ando
    Mamoru Hirohata
    World Journal of Gastroenterology, 2009, 15 (13) : 1650 - 1652
  • [36] Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir
    Heo, Nae-Yun
    Lim, Young-Suk
    Lee, Han Chu
    Chung, Young-Hwa
    Lee, Yung Sang
    Suh, Dong Jin
    JOURNAL OF HEPATOLOGY, 2010, 53 (03) : 449 - 454
  • [37] Severe acute exacerbation of HBeAg-negative chronic hepatitis B has good maintained response to lamivudine treatment
    Chan, H.
    Wong, V.
    Hui, A.
    Tsang, S.
    Chan, J.
    Chan, H.
    Wong, G.
    Sung, J.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S97 - S98
  • [38] Rhabdomyolytic syndrome during the lamivudine therapy for acute exacerbation of chronic type B hepatitis
    Yahagi, K
    Ueno, Y
    Mano, Y
    Shimosegawa, T
    LIVER TRANSPLANTATION, 2002, 8 (12) : 1198 - 1199
  • [39] Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy
    Jia-Li Wang
    Xin-Fang Du
    Shao-Long Chen
    Yi-Qi Yu
    Jing Wang
    Xi-Qi Hu
    Ling-Yun Shao
    Jia-Zhen Chen
    Xin-Hua Weng
    Wen-Hong Zhang
    World Journal of Gastroenterology, 2015, 21 (32) : 9598 - 9606
  • [40] Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy
    Honkoop, P
    de Man, RA
    Niesters, HGM
    Zondervan, PE
    Schalm, SW
    HEPATOLOGY, 2000, 32 (03) : 635 - 639
12345